Drug Search Results
More Filters [+]

Anivamersen

Alternative Names: anivamersen
Latest Update: 2014-10-23
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: FIXa Inhibitor

Novel Mechanism: Yes

Modality: Nucleic Acid

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Tobira
Company Location: SOUTH SAN FRANCISCO CA 94080
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Anivamersen

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events

Date

Type

Title